Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

IgE-mediated hypersensitivity reaction and desensitization to glatiramer acetate in a pediatric patient.
Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
Gavin Giovannoni on why time matters in multiple sclerosis.
An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.
How similar are commonly combined criteria for EDSS progression in multiple sclerosis?
Is electroconvulsive therapy safe in multiple sclerosis?
Crowdsourced research: Many hands make tight work.
[Multiple sclerosis and microRNA].
Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.
Postnatal lethality and abnormal development of foregut and spleen in Ndrg4 mutant mice.
Lymphocytic hypophysitis associated with pediatric multiple sclerosis.
Antibody patterns vary arbitrarily between cerebrospinal fluid and aqueous humor of the individual multiple sclerosis patient: Specificity-independent pathological B cell function.
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
Serostatus of Epstein-Barr virus in Iranian MS patients.
Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center.
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemia.
Smoking worsens multiple sclerosis prognosis: Two different pathways are involved.
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
Analyst insight: ECTRIMS 2012 congress highlights: Promising data offers hope for progressive MS
Does Natalizumab Therapy Benefit Patients With Multiple Sclerosis?
Role of phospholipase A(2)s and lipid mediators in secondary damage after spinal cord injury.

Pages